Marquette Asset Management »

Kinnate Biopharma shares owned by Marquette Asset Management

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Marquette Asset Management from 13F filings

Historical chart of Marquette Asset Management investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Marquette Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Marquette Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $142k 60k 2.37

More positions owned by Marquette Asset Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Schwab Strategic Tr Us Dividend Eq (SCHD)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core Us Aggbd Et (AGG)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Ser Tr S&p Kensho New (KOMP)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Rus 1000 Val Etf (IWD)
First Tr Dow Jones Select Mi Com Shs Annual (FDM)

View all positions for Marquette Asset Management

Top funds holding Kinnate Biopharma

OrbiMed Advisors
Tang Capital Management
Lynx1 Capital Management
Viking Global Investors
Vanguard Group
Deltec Asset Management
Millennium Management
BML Capital Management
Citadel Advisors
GSA Capital Partners
Two Sigma Investments
Acuitas Investments
Equitec Proprietary Markets
Marshall Wace
Goldman Sachs Group

View all funds holding Kinnate Biopharma